UGT1A1 genotyping: a predictor of irinotecan-associated side effects and drug efficacy?

Published 2009 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
UGT1A1 genotyping: a predictor of irinotecan-associated side effects and drug efficacy?
Authors
Keywords
-
Journal
ANTI-CANCER DRUGS
Volume 20, Issue 10, Pages 867-879
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2009-10-12
DOI
10.1097/cad.0b013e328330c7d2

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.